NextCure, Inc. (NXTC)
NASDAQ·Healthcare·Biotechnology
$2.06
-7.62%
Mkt Cap $33.52M
Analyst Ratings
No recent rating data.
Price Target (3 analysts)
$15.00
Range $15.00 – $15.00
Implied Upside
+628.2%
Consensus $15.00 vs current $2.06
NASDAQ·Healthcare·Biotechnology
$2.06
-7.62%
Mkt Cap $33.52M
No recent rating data.
Price Target (3 analysts)
$15.00
Range $15.00 – $15.00
+628.2%
Consensus $15.00 vs current $2.06